M Fiegl

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

R. Greil, M. Fiegl, H. Hausmaninger, 2003, Leukemia research.

Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.

M. Fiegl, S. Roka, J. Ackermann, 1998, Blood.